financetom
Business
financetom
/
Business
/
Canadian Western Bank Price Target Raised to $51 at RBC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Western Bank Price Target Raised to $51 at RBC
Jun 18, 2024 5:34 AM

08:13 AM EDT, 06/18/2024 (MT Newswires) -- RBC Capital Markets raised its price target on Canadian Western Bank ( CWESF ) to $51 from $28.

Analyst Darko Mihelic maintained a Sector Perform rating on shares of the Edmonton, Alberta-based bank following the June 11 announcement that it will be acquired by National Bank of Canada ( NTIOF ) .

"We believe that the acquisition price is attractive for CWB shareholders," Mihelic said in a note to clients.

"We believe CWB is a solid bank franchise," the analyst said. "It has a large presence in Western Canada, and we believe this will complement NA's footprint, which is predominantly in Quebec."

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hotel Operator Marriott Slips After Mixed Q1 Earnings
Hotel Operator Marriott Slips After Mixed Q1 Earnings
May 1, 2024
Marriott International Inc ( MAR ) shares are trading lower after the company's first-quarter adjusted EPS missed estimates. The company reported first-quarter FY24 sales growth of 6.5% year-on-year to $5.98 billion, beating the analyst consensus estimate of $5.93 billion. Comparable systemwide constant dollar RevPAR increased 4.2% worldwide, 1.5% in the U.S. & Canada, and 11.1% in international markets, compared to...
Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration
Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration
May 1, 2024
10:46 AM EDT, 05/01/2024 (MT Newswires) -- Editas Medicine ( EDIT ) said Wednesday that it has extended its collaboration with Bristol-Myers Squibb ( BMY ) in autologous and allogeneic alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases for another two years. The company said Bristol-Myers has opted for 13 different programs across 11 gene targets...
Market Chatter: Block Under Probe for Alleged Compliance Malpractices
Market Chatter: Block Under Probe for Alleged Compliance Malpractices
May 1, 2024
10:46 AM EDT, 05/01/2024 (MT Newswires) -- Block (SQ) is said to be under probe for alleged compliance lapses at its Square and Cash App units, NBC News reported Wednesday, citing two unnamed sources familiar with the matter. NBC said prosecutors from the Southern District of New York are looking into the company's documents and internal practices after a former...
Market Chatter: Citigroup Could Reportedly See Big Hit to Loan Book From Climate Action Fight
Market Chatter: Citigroup Could Reportedly See Big Hit to Loan Book From Climate Action Fight
May 1, 2024
10:45 AM EDT, 05/01/2024 (MT Newswires) -- Citigroup's ( C ) loan book could suffer billions of dollars of losses should the world speed up efforts to combat climate change, Reuters reported, citing a confidential analysis prepared by the bank that it reviewed. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved